JB Pharma publishes its maiden sustainability report
Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%
Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%
UNICEF award is worth US $98.755 million for supply of around 99.70 million doses during calendar years 2023-2027
Azelis’ customers now have access to products including the well-established Polyglykol portfolio, as well as a brand-new range of Motusflex and VitiPure excipients.
The Allurion Program is suited for people who are unable to achieve their weight-loss goals by dieting alone or for those who do not want to, or cannot, undergo invasive surgery or endoscopy
Proceeds from the proposed issue will be utilized to part finance Balaxi’s planned EU GMP-compliant manufacturing facility for Oral Solid Dosages and Liquid Injectables at TSIIC Pharma Formulations SEZ
We are launching the five new products in the new manufacturing facility and they're all pharmaceuticals and this should lead to an increase in pharma numbers.
This dense phase often resembles liquid droplets exhibiting higher protein density and weaker molecular motion than the surrounding medium.
The integrated capabilities at Unit 2 offer significant operational flexibility, greater efficiency, and varied scope within the same premise
ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.
The acquisition continues the growth and expansion course of the ALPLApharma business division established in 2019
Subscribe To Our Newsletter & Stay Updated